- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03757663
UV Dosimetry Feedback in NMSC Patients
September 4, 2019 updated by: University of Colorado, Denver
UV Dosimetry Feedback in Non-Melanoma Skin Cancer Patients
This study aims to characterize UV exposures among NMSC patients (those with a history of skin cancer) and to pilot an innovative behavioral intervention to decrease modifiable UV exposures.
It will use UV dosimeters to objectively measure UV exposure and provide time and activity specific UV data on an individual level.
These data will be used to develop a targeted and personalized behavioral feedback plan with counseling aimed at effective sun exposure behavior change
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
The study will focus on helping to prevent NMSC and its associated morbidity through learning when patients are unintentionally exposed to extreme UV radiation.
It will then help to create manageable and realistic behavioral interventions to reduce exposure, while also educating patients of the dangers of abundant sun exposure.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients between ages 18 and 50.
- Must be diagnosed with non-melanoma skin cancer.
Exclusion Criteria:
- Patients, who at the discretion of the clinician, are too ill or sick.
- Non-English speaking patients.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: UV Dosimeter
UV Dosimeter will measure participants' UV exposure for two separate 3-week periods.
|
Participants will self-report their knowledge and attitudes related to UV exposure.
They will then wear a dosimeter for 3 weeks.
After, the study team will counsel the participants on their UV levels and exposure, creating a personal plan and advice for avoiding sun exposure before letting the participants wear the dosimeter for an additional 3 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identify Discrepancies of Self-Reported Sun Exposure and Actual Sun Exposure
Time Frame: Start of study to end of study, up to 3 months
|
Measured using individual dosimeters and comparing it to what participants state they believe their level of sun exposure is
|
Start of study to end of study, up to 3 months
|
|
Identify Discrepancies of Self-Reported Sun Exposure and Actual Sun Exposure
Time Frame: Start of study to end of study, up to 3 months
|
Compare specific sun exposure behaviors responsible for the level of exposure versus what could be done to lessen it
|
Start of study to end of study, up to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Behavioral Intervention and immediate follow-up
Time Frame: Start of study to end of study, up to 3 months
|
Participants will receive a personalized feedback plan and the success of the plan will be measured through individual dosimetry.
We will track real time change in sun exposure based on repeat UV dosimetry.
|
Start of study to end of study, up to 3 months
|
|
Long Term Follow Up - longitudinal change in sun exposure based on dosimetry
Time Frame: Start of study to end of study, up to 3 months
|
Track the longitudinal change in sun exposure comparing baseline UV dosimetry measurements to 3 month follow up dosimetry measurements to determine if the changes observed in outcome 3 are maintained.
|
Start of study to end of study, up to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Myles Cockburn, PhD, University of Colorado, Denver
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 12, 2018
Primary Completion (Actual)
August 30, 2019
Study Completion (Actual)
August 30, 2019
Study Registration Dates
First Submitted
November 26, 2018
First Submitted That Met QC Criteria
November 26, 2018
First Posted (Actual)
November 29, 2018
Study Record Updates
Last Update Posted (Actual)
September 6, 2019
Last Update Submitted That Met QC Criteria
September 4, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-2134.cc
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Non-Melanoma Skin Cancer
-
Dartmouth-Hitchcock Medical CenterDartmouth CollegeRecruitingNon-Melanoma Skin Cancer (NMSC) | Benign Skin GrowthUnited States
-
Skin Analytics LimitedInnovate UKCompleted
-
Assiut UniversityNot yet recruitingNon-melanoma Skin Cancer
-
Assistance Publique - Hôpitaux de ParisRecruitingSkin Cancer, Non-MelanomaFrance
-
Xoft, Inc.CompletedNon-melanoma Skin CancerUnited States
-
Technische Universität DresdenCompletedNon-melanoma Skin CancerGermany
-
Assiut UniversityCompleted
-
Skin Analytics LimitedInnovate UKCompleted
-
University of Alabama at BirminghamCompleted
Clinical Trials on UV Counseling
-
University of Colorado, DenverCompletedNevi and MelanomasUnited States
-
University of MinnesotaCompletedProteomicsUnited States
-
Emergent BioSolutionsQuintiles, Inc.; Unither VirologyCompleted
-
Temple UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Active, not recruitingDiarrhea | Respiratory Viral Infection | Gastrointestinal Infection | Waterborne DiseasesUnited States
-
University of MichiganArchimedes Innovations, PbcTerminatedHealthy VolunteersUnited States
-
Temple UniversityPennsylvania Department of HealthCompletedRespiratory Viral Infection | Gastrointestinal InfectionUnited States
-
Cedars-Sinai Medical CenterAytu BioPharma, Inc.Completed
-
Johns Hopkins UniversitySkin of Color SocietyCompletedAcne Keloidalis NuchaeUnited States
-
Alcon ResearchCompletedRefractive Error